Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison

• Asıl Yazarlar: David Cherney (Yazar), Kerstin Folkerts (Yazar), Paul Mernagh (Yazar), Mateusz Nikodem (Yazar), Joerg Pawlitschko (Yazar), Peter Rossing (Yazar), Neil Hawkins (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Taylor & Francis Group, 2024-07-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

This study aimed to close an evidence gap concerning the relative efficacy of finerenone versus SGLT2is in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). Canagliflozin was selected as a proxy for the SGLT2i class. Patient-level data of two randomized controlled trials (RCTs) o...